Provided by Tiger Trade Technology Pte. Ltd.

Viridian Therapeutics, Inc.

19.40
+0.41002.16%
Post-market: 19.400.00000.00%16:04 EDT
Volume:1.51M
Turnover:29.28M
Market Cap:2.20B
PE:-5.61
High:19.55
Open:19.16
Low:18.92
Close:18.99
52wk High:34.29
52wk Low:13.18
Shares:113.29M
Float Shares:101.00M
Volume Ratio:0.80
T/O Rate:1.50%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.4579
EPS(LYR):-3.3245
ROE:-65.74%
ROA:-30.16%
PB:3.90
PE(LYR):-5.84

Loading ...

Viridian Therapeutics' Lumvoa Off to 'Stronger Start' Than Anticipated, RBC Says

MT Newswires Live
·
Sep 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Sep 22

Viridian Therapeutics, Inc. : RBC Raises Target Price to $38 from $36

THOMSON REUTERS
·
Sep 22

Sling Therapeutics Raises $123 Million to Advance Thyroid Eye Disease Drug

Reuters
·
Sep 16

Viridian Therapeutics Joins Wells Fargo Annual Healthcare Conference Fireside Chat

Reuters
·
Sep 03

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Teladoc (TDOC) and Protagonist Therapeutics (PTGX)

TIPRANKS
·
Sep 01

Viridian Therapeutics Chief Legal Officer Jennifer Tousignant Disposes of Common Shares Worth $348,194

Reuters
·
Aug 21

Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Aug 20

Viridian Therapeutics (VRDN) Gets a Buy from Truist Financial

TIPRANKS
·
Aug 13

Is Viridian Therapeutics' (VRDN) Widening Losses Despite Higher Revenue Reframing Its Risk Reward Profile?

Simply Wall St.
·
Aug 10

Viridian Therapeutics (VRDN) Receives a Buy from Evercore ISI

TIPRANKS
·
Aug 10

Viridian Therapeutics (VRDN) Receives a Buy from LifeSci Capital

TIPRANKS
·
Aug 07

Viridian Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Viridian Therapeutics Q2 Net Loss Widens as Lumvoa Launch Lifts Costs

Reuters
·
Aug 06

Viridian Net Loss Widens to $127.12 Million in Q2 FY26; SG&A Expenses Climb to $54.98 Million

Reuters
·
Aug 06

Viridian Therapeutics Highlights Recent Business Progress and Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 06

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Aug 05

How Positive Elegrobart REVEAL-1 Phase III Data Could Impact Viridian Therapeutics (VRDN) Investors

Simply Wall St.
·
Jul 30

Wells Fargo Reaffirms Their Buy Rating on Viridian Therapeutics (VRDN)

TIPRANKS
·
Jul 20

Wedbush Sticks to Its Buy Rating for Viridian Therapeutics (VRDN)

TIPRANKS
·
Jul 13